Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $640.57B | 41.3x | 3.55 | $79.70 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.7% Upside | Upgrade to Pro+ | |
Seven i ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $40.40B | 28.4x | -1.32 | $15.71 | 4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seven & i Co | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $40.40B | 28.4x | -1.32 | $15.33 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kroger | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $39.82B | 18.4x | -1.13 | $55.21 | 7.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.6% Upside | Upgrade to Pro+ | |
Sysco | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $37.81B | 19.7x | 1.63 | $76.97 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.5% Upside | Upgrade to Pro+ | |
Fomento Economico Mexicano | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $35.81B | 26.8x | -0.33 | $103.23 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.7% Upside | Upgrade to Pro+ | |
Tesco PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $32.67B | 22x | 0.21 | $4.89 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tesco PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $32.67B | 22x | 0.21 | $14.53 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -15.1% Downside | Upgrade to Pro+ | |
Koninklijke Ahold NV | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $31.68B | 15.8x | -0.75 | $33.90 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Koninklijke Ahold ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $31.68B | 15.8x | -0.75 | $34.22 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.8% Upside | Upgrade to Pro+ | |
Aeon ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $23.50B | 104.2x | 1.64 | $27.63 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CP All ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $17.35B | 26.6x | 0.57 | $16 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coles Group | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $16.63B | 22.4x | 12.31 | $11.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
US Foods | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $14.48B | 27.7x | 2.21 | $59.20 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.3% Upside | Upgrade to Pro+ | |
Caseys | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $14.15B | 27.5x | 2.4 | $382.07 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.8% Upside | Upgrade to Pro+ | |
Jeronimo Martins SGPS SA ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $11.48B | 16.1x | -2.8 | $36.67 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.3% Upside | Upgrade to Pro+ | |
Performance Food Group Co | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $11.39B | 25.9x | 2.6 | $73 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.3% Upside | Upgrade to Pro+ | |
Carrefour SA PK | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $11.09B | 12.9x | -0.21 | $3.36 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.1% Upside | Upgrade to Pro+ | |
Albertsons | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $11.01B | 9.8x | -0.75 | $19.01 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.2% Upside | Upgrade to Pro+ | |
Sendas Distribuidora | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $10.90B | 92.3x | -0.7 | $8.06 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sprouts Farmers | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $10.18B | 31.7x | 0.94 | $101.73 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.7% Downside | Upgrade to Pro+ | |
Marks & Spencer Group Plc | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $9.29B | 16.1x | 1.01 | $9.45 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9.7% Downside | Upgrade to Pro+ | |
Marks and Spencer | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $9.29B | 16.1x | 1 | $4.45 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shoprite ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $9.11B | 26x | 4.07 | $16.83 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
J Sainsbury PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $9.03B | 50.3x | -1.43 | $15.71 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -14.2% Downside | Upgrade to Pro+ | |
Raia Drogasil ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $8.20B | 43.2x | 36.53 | $4.74 | -4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.1% Upside | Upgrade to Pro+ | |
Kesko ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $8.02B | 17.1x | -0.72 | $10.13 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dino Polska ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $7.75B | 21.4x | 2.4 | $39.59 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Walgreens Boots | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $7.61B | -1.3x | 0.02 | $8.84 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.2% Upside | Upgrade to Pro+ | |
Etablissementen Franz Colruyt ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $6.14B | 5.3x | 0.01 | $13.15 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |